Immunopotentiation against internal parasites.
The economic importance of livestock losses attributed to internal parasites has led to the need of developing and successfully employing effective antiparasitic vaccines. An increasingly important strategy in the development of more effective vaccines is the preparation and use of immunopotentiators or adjuvants. Immunopotentiators or adjuvants have been used effectively in combination with antigen(s) or alone to protect animals against internal parasites. The use of immunopotentiators for specific and nonspecific stimulation of protective immunity against internal parasites is reviewed.
D000276:Adjuvants, Immunologic; D000818:Animals; D001500:BCG Vaccine / Q000276:immunology; D001428:Bacterial Vaccines / Q000276:immunology; D002417:Cattle; D003311:Cord Factors / Q000276:immunology; D000939:Epitopes; D000882:Haplorhini; D006790:Host-Parasite Interactions; D007106:Immune Sera / Q000276:immunology; D051379:Mice; D010271:Parasites / Q000276:immunology*; D010272:Parasitic Diseases / Q000276:immunology*; D051381:Rats; D012756:Sheep; D014165:Transfer Factor / Q000276:immunology
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; D001428:Bacterial Vaccines; D003311:Cord Factors; D000939:Epitopes; D007106:Immune Sera; D014165:Transfer Factor